Company / Capital Expenditures
Wave Life Sciences Ltd. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$718.0K
FY2025
5-year range
$560.0K / $1.3M
FY2021-FY2025
Trend
-23.5%
vs FY2024
Sector context
#126 of 194
Health Care
What the data says
At $718,000, Wave Life Sciences Ltd.'s capital expenditures ranks #126 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $560,000 in FY2022 to $19M in FY2019.
Based on SEC 10-K filings.
$718,000 in FY2025 with a 5-year CAGR of -28.8%.
Declined from $1M to $718,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +8.6%
- 5-Year CAGR
- -28.8%
- 10-Year CAGR
- -
Sector benchmark
#126 of 194 in Health CareTop 65% of 194This company $718.0K Sector average $117.5M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -28.8%, indicating a declining trend.
- In FY2025, capital expenditures decreased 23.5% year-over-year.
- Ranks #126 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $718.0K | -23.5% |
| FY2024 | $938.0K | -15.9% |
| FY2023 | $1.1M | +99.1% |
| FY2022 | $560.0K | -58.1% |
| FY2021 | $1.3M | -65.8% |
| FY2020 | $3.9M | -79.3% |
| FY2019 | $18.9M | +90.0% |
| FY2018 | $9.9M | -47.4% |
| FY2017 | $18.9M | +239.3% |
| FY2016 | $5.6M | +11744.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026